Our Partners

line-img

Our Partners

Due to confidentiality restrictions we cannot disclose all of our partnerships.

Medigene

Structured Immunity and Medigene are collaborating to improve how T cell receptors (TCRs) are validated and optimized for therapeutic use. Combining Medigene's TCR development expertise with Structured Immunity's structural immunology technologies, the partnership aims to evaluate the recognition properties and specificity of a lead TCR candidate.

Medigene